Abstract During the development of the pituitary gland, distinct hormoneproducing cell types arise from a common population of ectodermal progenitors, providing an instructive model system for elucidating the molecular mechanisms of patterning and cell type specification in mammalian organogenesis. Recent studies have established that the development of the pituitary occurs through multiple sequential steps, allowing the coordinate control of the commitment, early patterning, proliferation, and positional determination of pituitary cell lineages in response to extrinsic and intrinsic signals. The early phases of pituitary development appear to be mediated through the activities of multiple signaling gradients emanating from key organizing centers that give rise to temporally and spatially distinct patterns of transcription factor expression. The induction of these transcriptional mediators in turn acts to positionally organize specific pituitary cell lineages within an apparently uniform field of ectodermal progenitors. Ultimately, pituitary cell types have proven to be both specified and maintained through the combinatorial interactions of a series of cell-type-restricted transcription factors that dictate the cell autonomous programs of differentiation in response to the transient signaling events.
INTRODUCTION
Understanding the molecular mechanisms by which diverse and specialized cell types emerge during the development of multicellular organisms remains a critical question in biology. Based initially on genetic studies in Drosophila melanogaster, early patterning events in vertebrate organogenesis have been found to be coordinated through the interplay of highly organized signaling cues (Edlund & Jessell 1999) . Extrinsic signals, provided in the form of secreted morphogens or through transmembrane signaling receptors, create local environments for the positional determination of progenitor cell types and orchestrate the patterning of organs through the induction of specific proliferative or apoptotic events. These signals are subsequently translated into the intrinsic or cell-autonomous determination 0147-006X/01/0301-0327$14.00 programs, in part through modulation in the activity or expression of cell typerestricted transcriptional regulators. Extrinsic signaling events have been demonstrated to be mediated through the activities of multiple members of a relatively small family of different classes of molecules that include members of the transforming-growth-factor beta superfamily, Wnts, hedgehogs, fibroblast growth factors (FGFs), epidermal growth factors and retinoids (reviewed by Hogan 1999) . How such an apparently small repertoire of signaling molecules can lead to the patterning of diverse organs across multiple species remains to be fully understood.
The development of the pituitary gland has provided a particularly useful model system in which to study these complex processes because the cell types are derived from a common ectodermal primordium and arise in a distinct spatial and temporal fashion in response to intrinsic and extrinsic signals. The pituitary gland is of dual embryonic origin and arises through intimate association of neural ectoderm and oral roof ectoderm. The mature pituitary gland is ultimately composed of three lobes; the anterior and intermediate lobes contain the six hormone-secreting cell types and are derived from oral ectoderm, whereas the posterior lobe, containing the axonal projections emanating from the hypothalamus, is derived from neural ectoderm.
Each cell type of the anterior pituitary gland is characterized by the secretion of one or more trophic hormones that regulate a diverse range of important biological processes in response to signals from the hypothalamus and peripheral organs ( Figure 1 ). Two cell types synthesize proopiomelanocortin (POMC), which is cleaved by proteolytic processing to generate melanocyte-stimulating hormone in melanotropes and adrenocorticotropin (ACTH) in corticotropes. ACTH regulates metabolic function through stimulation of glucocorticoid synthesis in the adrenal cortex whereas melanocyte-stimulating hormone regulates melatonin synthesis in the epidermis in some vertebrate species. Somatotropes produce growth hormone (GH) and regulate linear growth and metabolism, whereas lactotropes secrete prolactin (Prl) which regulates milk production in females. Thyrotropes produce thyroid-stimulating hormone (TSH), which controls the secretion of thyroid hormone from the thyroid gland. Gonadotropes produce luteinizing hormone (LH) and follicle-stimulating hormone (FSH) which regulate reproductive development and function. TSH, LH, and FSH are heterodimeric glycoproteins consisting of a common α subunit (α-GSU) and a specific β subunit.
In recent years considerable progress has been made in identifying the critical transcription factors responsible for the appearance of these distinct cell phenotypes (Watkins-Chow & Camper 1998 , Dasen & Rosenfeld 1999b , Sheng & Westphal 1999 ). An unresolved issue has been the mechanisms by which these cell types arise from a common population of progenitor cells in response to morphogen cues. In this review, we describe recent studies that have investigated the roles of signaling gradients that govern the organ commitment, patterning, and positional determination of cell types in the developing pituitary gland. We illustrate the mechanisms by which multiple signaling centers can act to positionally establish cell types through the induction of overlapping patterns of transcription factor expression. We also focus on the aspects of pituitary cell type specification that are ultimately mediated through the combinatorial interactions of a series of cell type-specific or -restricted transcription factors which serve to establish the cell type-specific molecular memory of the transient signaling events. demonstrated to play critical roles in patterning and cell type specification in several species [reviewed by Hogan (1996) ]. BMP4 is expressed in the ventral diencephalon as the infundibulum makes direct contact with Rathke's pouch at e8.5-e9.0 and may be one of the early signaling factors required for the initial commitment of a subpopulation of oral ectodermal cells to form the pituitary gland ( Figure 2 ) (Ericson et al 1998 , Treier et al 1998 . The role of BMP4 signaling in pituitary organogenesis has been investigated in vivo by targeted expression of the BMP2/4 antagonist Noggin, using the regulatory sequences of the Pitx1 gene to target expression throughout the oral ectoderm and within Rathke's pouch. In Pitx1/Noggin-transgenic mice, pituitary development is arrested at e10, and there is a complete absence of all pituitary cell types and a failure of the characteristic ventral proliferation of cells from the pouch beginning at e11.5 (Treier et al 1998) . Based on the similarity of this phenotype with that of mice with a targeted disruption of the Lhx3 (P-Lim/mLim3) gene (Seidah et al 1994 , Bach et al 1995 , Zhadanov et al 1995 , a LIM homeodomain protein critical for the determination of most pituitary cell types (Sheng et al 1996) , BMP4 signaling appears to be required in the initial phases of organ commitment.
The role of BMP signaling in early pituitary development has also been investigated in BMP4 gene-deleted animals, in which the initial invagination of Rathke's pouch fails to occur (Takuma et al 1998) . Because most BMP4 knockout animals die at or near the time of pituitary organ commitment (Winnier et al 1995) , definitive proof of a requirement for BMP4 signaling in the initial invagination event will await the generation of a neural-specific knockout animal. Thus the signals required for the initial invagination of Rathke's pouch are still unclear, although a recent study has suggested a potential role for the notochord in this process .
Infundibular Fibroblast Growth Factor Signaling Provides Proliferative and Positional Cues to Rathke's Pouch
In addition to BMP4, multiple members of the FGF family are expressed in the infundibulum and have been demonstrated to play critical roles in both the organ morphogenesis and positionally restricted determination of pituitary cell lineages. Subsequent to BMP4 induction, FGF8 and FGF10 are expressed in a temporally and spatially overlapping manner within the infundibulum throughout the early phases of pituitary development. The role of FGF8 has been investigated both in vitro using pituitary explant cocultures and in vivo through generation and analysis of transgenic and gene-disrupted animals. Cultivation of Rathke's pouch with ventral diencephalon has provided strong evidence for an instructive role for FGF signaling in the early phases of pituitary development (Treier et al 1998 , Ericson et al 1998 . In culture, the infundibulum is both required and sufficient for the induction of Lhx3/P-Lim gene expression in pouch explants. In the absence of the infundibulum, Lhx3 expression can be induced by culture of explants with FGF8 or FGF2, suggesting that FGFs are required for the maintenance or initial induction of Lhx3 gene expression. Additionally, expression of Lhx3 early in development has been observed to be highest in the dorsal aspect of the developing gland (Ericson et al 1998) , consistent with its expression being regulated, in part, by dorsal signaling molecules.
The role of dorsal FGF signaling has also been studied in vivo through generation of transgenic animals misexpressing FGF8 in the ventral regions of the pituitary under control of the regulatory sequences for the αGSU gene, which targets expression to Rathke's pouch and later to ventral cell types. In αGSU/FGF8-transgenic animals, most ventral and intermediate cell types are absent, and the pituitary is characterized by a hyperplasia of corticotropes and melanotropes, consistent with a patterning role for FGFs in the positional determination of dorsally arising pituitary cell types (Treier et al 1998) . This phenotype is also associated with an expanded population of pouch ectoderm, similar to the dysmorphogenesis of Rathke's pouch observed in Ames dwarf mice (Sornson et al 1996 , Gage et al 1996a , suggesting that FGFs also contribute to the proliferation of pituitary progenitor cells. The requirement for FGF8 has been further suggested based on analysis of T/ebp gene-deleted mice, in which FGF8 fails to be expressed in the ventral diencephalon, and this absence of FGF8 signaling has been suggested to be directly linked to a loss of Lhx3 expression (Takuma et al 1998) .
Analysis of mice deleted for FGF receptor type 2 (FGFR2) has provided further genetic evidence for an essential role for FGF signaling. The FGFR2 gene is differentially spliced into two receptor isoforms, each of which displays different ligand specificities. By gene-targeting strategies, mice lacking the IIIb isoform of FGFR2 were generated, which presumably would abolish signaling through FGFs 1, 3, 7, and 10 (De Moerlooze et al 2000) . In FGFR2 (IIIb)-null mice, Rathke's pouch forms but rapidly undergoes apoptosis with the pituitary becoming completely absent by e14.5. These studies suggest a critical role for FGF10 signaling for the continued proliferation of the pouch ectoderm, although pituitary defects in FGF10-deleted mice (Min et al 1998 , Sekine et al 1999 have not yet been reported. Thus, similar to the well-established roles of FGFs in limb bud and lung morphogenesis (Martin 1998) , FGF8 and FGF10 appear to play critical roles in the early patterning and proliferation events in pituitary organogenesis.
Bone-Morphogenetic Protein 2 Signaling Positionally Specifies Ventral Pituitary Cell Lineages
In addition to the dorsal BMP4 and FGF8/10 signals emanating from the infundibulum, early patterning events in pituitary organogenesis are also governed through the activities of ventral and pouch-intrinsic signals, which contribute to the establishment of the positional identity of ventral pituitary cell types. Expression of BMP2 is initially detected in the most ventral aspect of the invaginating gland at e9.5, at the ventral boundary between Rathke's pouch and Sonic hedgehog (Shh) expression throughout the oral ectoderm (Treier et al 1998) . BMP2 expression later expands throughout the pouch by e12.5 with expression of BMP2/4 an-tagonist chordin in the caudal mesenchyme, potentially serving to maintain a ventrodorsal BMP2 gradient (Figure 2 ). Subsequent to the closure of Rathke's pouch and its separation from the oral ectoderm, BMP2 expression is also detected in the ventral juxtapituitary mesenchyme, in a region adjacent to the pituitary cell types characterized by expression of ventrally induced transcription factors GATA-2, Isl-1, and P-Frk as well as the hormone subunit αGSU (Treier et al 1998 , Ericson et al 1998 .
The role of BMP2 signaling has been investigated in vivo through ventralized overexpression of BMP2/4 under the control of αGSU regulatory information, which leads to a dorsal expansion in the expression domains of ventral lineage markers Isl-1 and Msx-1 and the direct transcriptional induction of GATA-2 gene expression (Treier et al 1998) . Similarly, cultivation of Rathke's pouch in the presence of BMP2 is sufficient for the induction of Isl-1 and αGSU expression (Ericson et al 1998) . Based on the ability of BMP2 to induce αGSU gene expression, an early marker for the thyrotrope and gonadotrope cell populations, these studies suggest that BMP2 signaling specifies the progenitors that will later give rise to ventral pituitary cell types. The attenuation of BMP signaling, however, is also required for the developmental progression of pituitary cell types because overexpression of BMP in vivo prevents terminal differentiation, possibly due to maintained expression of Msx-1 (Treier et al 1998) , a repressor homeodomain factor known to inhibit terminal differentiation in myogenesis (Song et al 1992) .
Opposing Bone-Morphogenetic Protein-and Fibroblast Growth Factor-Signaling Gradients
A critical component by which physically opposing signaling gradients can act to positionally determine cell types has emerged from studies on dorsal-FGF and ventral-BMP2 signaling in pituitary development. Acting on a uniform cell population, multiple signaling pathways can be hypothesized to exert either cooperative or antagonistic effects on cellular proliferation and/or differentiation. In pituitary explant cultures, the ability of the infundibulum or FGFs to induce Lhx3 gene expression coincides with the restricted expression of the BMP2-induced genes Isl-1 and αGSU away from the source of the FGF signal (Ericson et al 1998) . Similarly, the ability of ventralized expression of FGF8 to prevent the appearance of ventral and intermediate cell types in vivo can be attributed to the inhibition of ventral BMP2 signaling (Treier et al 1998) . Conversely, while cultivation of Rathke's pouch with BMP2/4 initiates the expression of the ventral markers Isl-1 and αGSU, it inhibits the expression of more dorsal cell type markers such as ACTH in vitro (Ericson et al 1998) and Pit-1 in vivo (Treier et al 1998) . Thus antagonistic and opposing dorsal → ventral FGF8 and ventral → dorsal BMP2 gradients appear to be associated with the positional determination of dorsal-and ventral-cell types, respectively. These opposing gradients parallel events in tooth development, in which opposing BMP and FGF gradients establish differential domains of Pax9 expression and define specific regions of tooth morphogenesis (Neubuser et al 1997 , Peters & Balling 1999 .
Ventral Sonic Hedgehog Signaling and Compartmentalization of the Pouch
In the development of Drosophila appendages, the secreted protein Hedgehog (Hh) plays a crucial role in defining the border between the anterior and posterior compartments in the imaginal disk (Dahmann & Basler 1999) . A vertebrate homolog of Hh, sonic hedgehog (Shh), is expressed in several organizing centers during embryogenesis, where it exerts crucial patterning roles (Hammerschmidt et al 1997) . During the early development of the pituitary gland, Shh is expressed throughout the oral ectoderm but is excluded from the region that forms Rathke's pouch, creating a potential molecular compartmental boundary within the continuous ectoderm ( Figure 2 ).
Studies in several species have provided suggestive evidence for a role of Hedgehog signaling in early phases of pituitary morphogenesis. In Xenopus laevis it has been demonstrated that, in animal cap explants cultured with banded hedgehog, the homolog of the mammalian Indian hedgehog (ihh) gene, the expression domains of pituitary-restricted factors such as XANF-2 [a homolog of the mammalian homeodomain factor rpx/Hesx1 (Thomas & Rathjen 1992 , Hermesz et al 1996 ] are expanded, consistent with a role for Hedgehog signaling in control of proliferative events in pituitary development (Ekker et al 1995) . Similarly, in vivo ventral overexpression of Shh can expand the population of ventral pituitary cell types and modify levels of Lhx3 gene expression ( MT Treier & MG Rosenfeld, unpublished observation) .
Evidence for a patterning role for hedgehog signaling in pituitary-cell-type specification has emerged from genetic studies in zebrafish. The you-too (yot) mutant was initially characterized by defects in optic chiasm and somite development and more recently has been shown to display defects in pituitary development. Positional cloning of the yot locus identified the defective gene as the zebrafish homolog of the mammalian Gli2 zinc finger protein (Karlstrom et al 1999) . The Gli family of transcription factors are well established as downstream mediators of Hedgehog signaling and they act as positive or negative transcriptional regulators in multiple-organ systems (reviewed by Ruiz & Altaba [1999] ). In yot mutants, the rostral expression domains (analogous to the ventral domains in mice) of pituitary-specific transcription factors such as lim3 (Lhx3) and six3 are lost, with other pituitary-restricted factors such as nk 2.2 (Nkx2.2) completely absent. Given the sequential and cooperative roles that BMPs and Hedgehogs exert in limb and neural-tube development (Laufer et al 1994 , Dale et al 1997 , where Shh acts to induce expression of BMPs, Shh may act in a signaling cascade with BMP2 in the determination of ventral pituitary cell lineages.
Other Potential Morphogenetic Factors
Several other classes of signaling molecules have been implicated to exert roles in pituitary-cell-type specification. The Wnt proteins are a family of secreted proteins involved in a variety of early embryonic events and functions through transcriptional mediators such β-catenin and T-cell factor (reviewed by Eastman & Grosschedl 1999) . In the pituitary, Wnt4 and Wnt5a are expressed in the ventral diencephalon and within the cells of Rathke's pouch, respectively. In Wnt4-mutant mice, the pituitary is mildly hypocellular, with the ventral-cell types showing normal differentiation but incomplete expansion. Additionally, cultivation of Rathke's pouch with Wnt5a and BMP4 can induce expression of the early cell type marker αGSU (Treier et al 1998) . Thus Wnts and BMPs may act in synergy to expand pituitary cell lineages and induce cell determination programs.
Very little is currently known about the contribution of cytokines to development of mammalian organs outside the hematopoietic system, despite the potent ability of cytokines such as leukemia inhibitory factor (LIF) to maintain mouse embryonic stem cells in an undifferentiated state. A potential role for LIF in pituitary development was initially investigated in pituitary-derived cell lines where it was demonstrated that LIF can activate synthesis of the corticotrope-specific gene ACTH in combination with the hypothalamic peptide corticotropin-releasing hormone (Bousquet et al 1997) . The role of LIF was further investigated in vivo through generation of transgenic mice expressing LIF in differentiated cell types and during early pituitary ontogeny. In transgenic animals expressing LIF under control of αGSU regulatory information, LIF has a potent morphogenetic effect on pituitary development, because most cell types fail to properly differentiate, and the pituitary is characterized by the formation of ciliated cysts of Rathke's pouch and corticotrope hyperplasia (Yano et al 1998) . The formation of ciliated cells similar in morphology to cells present in the nasal epithelium suggests that many of the progenitor cells have been directed down a different, although related, developmental pathway. LIF therefore may act in concert with other signaling molecules to establish the identity of dorsal-cell phenotypes.
Retinoids are well established as morphogens in vertebrate organogenesis, and are involved in the patterning of cell types in many organs including the hindbrain, limbs, and neural tube [reviewed by Eichele (1997) ]. Investigations into the role of retinoic acid (RA) signaling in pituitary development have thus far focused primarily on the direct regulation of pituitary-specific genes, such as the genes for growth hormone (GH) and Pit-1, where RA can activate gene expression through ligand-dependent synergy of the RA receptor (RAR) with the POU homeodomain protein Pit-1 (Rhodes et al 1993 , Sanchez-Pacheco et al 1998 . Because the activation of these genes occurs subsequently to the initial patterning events, the contribution of retinoids to the earlier phases of pituitary development, if any, is unresolved. The expression profile of the RALDH2 gene, which encodes the enzyme that catalyzes the final reaction step in RA synthesis, has provided a useful marker for identifying the sites of RA activity during development. In addition to many other discrete regions of the embryo, RALDH2 is highly expressed in the developing pituitary as early as e10.5 (Niederreither et al 1997) , suggestive of a role for retinoid signaling in earlier phases of pituitary development.
TRANSCRIPTION FACTOR HIERARCHIES GOVERNING THE EARLY PHASES OF PITUITARY DEVELOPMENT LIM Homeodomain Factors as Selector Genes
Multiple members of the LIM homeodomain family of transcription factors are expressed in Rathke's pouch, including Lhx3 (P-Lim/mLim3), Lhx4 (Gsh4), and Isl-1. Lhx3 gene expression initiates coincident with the formation of Rathke's pouch at e9.5 and is one of the first transcription factors that is specifically expressed in the pouch and not throughout the oral ectoderm (Bach et al 1995 , Zhadanov et al 1995 . Targeted disruption of the genes for Lhx3 and Lhx4 have established that these factors play crucial roles in the earliest phases of pituitary organogenesis. In Lhx3-mutant mice, the rudiment of Rathke's pouch forms normally, but the pouch ectoderm fails to continue to proliferate and virtually all pituitary cell types are absent, with only a few corticotropes remaining (Sheng et al 1996) . A highly related factor, Lhx4, serves a redundant role to Lhx3 as Lhx4-/-mice also show severe defects in pituitary development but only within the context of Lhx3 heterozygote mutants (Sheng et al 1997) . In addition to the established roles of Lhx3 and Lhx4 in pituitary development, Lhx3 and Lhx4 are also required for the appearance of specific motor neuron types within the neural tube .
Whereas Lhx3 and Lhx4 are expressed broadly throughout Rathke's pouch in early pituitary ontogeny, Isl-1 is initially expressed throughout the pouch, but it later becomes restricted to the ventral-cell populations by e10.5. In Isl-1-mutant mice (Pfaff et al 1996) , the invagination of Rathke's pouch occurs normally, but the epithelial cells forming Rathke's pouch fail to proliferate (Takuma et al 1998) . Because Isl-1 expression can be induced by BMPs both in vivo and in vitro, its expression in the pituitary gland has been suggested to be under the dual regulation of both the dorsal-BMP4 and ventral-BMP2 signals (Ericson et al 1998) . Consistent with this hypothesis, the ventral restriction of Isl-1 expression correlates with down-regulation of the BMP4 signal in the infundibulum and the appearance of BMP2 within the pouch and the ventral juxtapituitary mesenchyme.
Pitx Homeodomain Factors
Two bicoid-related Pitx homeodomain factors are expressed throughout pituitary ontogeny, demonstrating distinct and overlapping patterns of expression. Pitx1 (formerly referred to as P-Otx and Ptx1) was identified in screens for factors interacting with the N terminus of the pituitary-specific POU homeodomain protein Pit-1 (Szeto et al 1996) and in a screen for factors regulating expression of the POMC gene promoter (Lamonerie et al 1996) . The Pitx1 gene is expressed in the earliest stages of pituitary organogenesis, initially at the anterior region of the neural plate in early mouse development, later becoming expressed throughout the oral ectoderm and subsequently in all pituitary cell types. Pitx1 is also expressed in several other discrete regions of the embryo, including the first branchial arch and hind limbs (Szeto et al 1996 , Lanctot et al 1997 . Targeted disruption of the Pitx1 gene leads to diminished expression of the terminal-differentiation markers for the ventral-gonadotrope and -thyrotrope pituitary cell types as well as defects in craniofacial and hind-limb morphogenesis , Lanctot et al 1999b . The defects in two pituitary cell types are consistent with the observation that the Pitx1 gene is preferentially expressed in the most ventral cell lineages (Lanctot et al 1999a) , suggesting that Pitx1 is either negatively regulated by dorsal-signaling or positively regulated by ventral-signaling molecules. The reduced cell numbers in only two lineages, despite the pan-pituitary expression of Pitx1, also suggests that the second Pitx gene, Pitx2, can compensate for loss of Pitx1 in the more dorsal cell types.
In the development of limbs, Pitx1 has also been shown to be critical for the components of transcriptional pathways that distinguish hind-limb from forelimb identity , Lanctot et al 1999b . In Pitx1-null mice, the hind limb assumes morphological features of the forelimb, and hind-limb-specific structures such as the patella are absent. Expression of the hind-limb-specific transcription factor Tbx4 is also markedly decreased in Pitx1-mutant mice, and Pitx1 is sufficient to induce expression of Tbx4 when misexpressed in the forelimb , Logan & Tabin 1999 . Thus Pitx1, in addition to its role in ventral-pituitary-cell types, is critical in developmental decisions in other organs. The Pitx2 gene was identified through the positional cloning of the gene responsible for the human disease Rieger syndrome, characterized by defects in eye, tooth, and umbilical cord development (Semina et al 1996) . Like Pitx1, Pitx2 gene expression is detectable in most cell types throughout early and late pituitary ontogeny but is also expressed in several other developing organs including the primordia of the heart, tooth, lung, gut, and eye. Pitx2 gene-deleted mice are characterized by multiple severe developmental defects including a failure of ventral-body-wall closure, altered cardiac positioning, lung isomerisms, and defects in tooth and pituitary organogenesis (Gage et al 1999 , Kitamura et al 1999 , Lin et al 1999 , Lu et al 1999 . In the pituitary, organogenesis is arrested in the early stages of development, subsequent to the contact of the infundibulum with Rathke's pouch and establishment of early signaling gradients. Although the initial invagination of the pouch and induction of Lhx3 gene expression occur normally, in Pitx2 mutant mice, the gland fails to progress beyond e10.5, and it is characterized by a hypoplasia of the pouch ectoderm and a failure of the ectodermal cells to proliferate ventrally and populate the pituitary gland.
Much attention has also been given to the role of Pitx2 in events governing the establishment of asymmetry in the early embryo [reviewed by Capdevila et al (2000) ], providing a potential model to understand Pitx2 gene regulation in the developing pituitary in response to early signaling events. In vertebrate embryogenesis, the earliest asymmetric event is manifested in the looping of the heart, which is governed by inductive events occurring through the node, notochord, and the lateral-plate mesoderm (LPM). Pitx2 is asymmetrically expressed in the left LPM, acts as a key determinant of "leftness" in multiple organ systems, and is regulated by the integrated activities of Shh, FGF8, and the transforming-growthfactor beta family member nodal. In mice, nodal and FGF8 appear to be required for the induction of Pitx2 expression on the left side of the LPM, whereas Shh prevents its expression on the right side because FGF8 mutants fail to express Pitx2 and Shh mutants show bilateral expression of Pitx2 on the LPM (Meyers & Martin 1999) . It is intriguing that a similar cross-regulatory cascade of signaling molecules modulates expression of Pitx2 within the pituitary.
Pitx and Lhx Factors Synergistically Regulate Pituitary Organogenesis and Pituitary-Specific Gene Expression
The striking similarity of the phenotypes of Pitx2 and Lhx3 gene-deleted mice suggests that these two classes of homeodomain factors collaborate to regulate the same or overlapping cohorts of pituitary-specific target genes. Indeed, LIM homeodomain factors can act synergistically with Pitx factors to activate expression of pituitary-specific genes such as αGSU (Bach et al 1997) . The synergy between Lhx and Pitx factors has been further shown to be mediated by the broadly expressed cofactors CLIM1/Lbd-2 and CLIM2/Lbd-1/NLI, which were identified in screens for proteins interacting with the LIM domain zinc finger (Agulnick et al 1996 , Jurata et al 1996 , Bach et al 1997 . A Drosophila homolog of CLIM/Lbd factors, called Chip, also modulates the activity of the LIM domain containing homeodomain Apterous (Morcillo et al 1997) , suggesting that this interaction represents a conserved aspect of the function of LIM homeodomain factors. In summary, the induction of Lhx3 gene expression in response to infundibular FGF signaling appears to be the critical step in the selection of oral ectoderm to assume the pituitary fate, allowing synergistic activation of pituitary-specific gene programs by Lhx3, Pitx2, and CLIM cofactors.
Ventral Progression and the Paired-Like Homeodomain Factors Prop-1 and Rpx
While the commitment and early proliferation of Rathke's pouch require the activities of the Lhx and Pitx genes, other factors are needed for the asymmetric progression of the ectoderm to generate the precursors of the hormone-secreting cell types. The proliferation of cell types from Rathke's pouch to populate the anterior lobe of the pituitary gland requires the activities of another homeodomain factor identified through positional cloning of the Ames dwarf (df ) locus. Genetic and phenotypic analysis of df mice that were deficient in at least three pituitary cell types ultimately led to the isolation of the pituitary-specific paired-like homeodomain factor Prophet of Pit-1 (Prop-1) (Buckwalter et al 1991 , Andersen et al 1995 , Gage et al 1996b , Sornson et al 1996 , Watkins-Chow et al 1997 . Prop-1 expression is detected in the pituitary coincident with closure of Rathke's pouch at e10.5, and it is expressed throughout the pouch, becoming down-regulated coincident with the appearance of pituitary-cell-type terminal-differentiation markers between e15.5 and e16.5. Although the induction of Pitx and Lhx gene family members occurs and is maintained normally, Prop-1-defective mice fail to activate Pit-1 gene expression, and subsequently fail to generate somatotropes, lactotropes, and thyrotropes. In Ames dwarf mice, the epithelial cells surrounding the lumen of Rathke's pouch fail to populate the anterior pituitary, generating expanded lumen and dysmorphogenesis of the pouch ectoderm (Sornson et al 1996 , Gage et al 1999a . Prop-1 may therefore function to allow nascent pituitary cell types to delaminate or asymmetrically progress from the epithelium of the pouch (Figure 3) .
In addition to its role in the determination of the three Pit-1-dependent cell lineages (somatotropes, lactotropes, and thyrotropes), Prop-1 also appears to be required for the generation of a fourth anterior pituitary cell type, the gonadotrope, because patients with combined pituitary hormone deficiency-bearing mutations in the human PROP1 gene are defective in gonadotropin hormone synthesis (Wu et al 1998 , Deladoey et al 1999 , Rosenbloom et al 1999 . This difference in the severity of phenotype between the mouse and human mutations can be attributed to differences in the functional consequences of various Prop-1 mutations. Whereas the mouse Prop-1 point mutation in the first helix of the homeodomain (S83P) still retains some ability to bind DNA, a subset of human PROP1 mutations in which the DNA-binding third helix of the homeodomain is deleted consistently are presented with severe defects in gonadotropin synthesis (Figure 3 ). These more severe human PROP1 mutations have also been reported to be present with defects in ACTH synthesis (Pernasetti et al 2000) , suggesting that Prop-1 functions in the appearance or expansion of all anterior pituitary cell lineages, including the non-Pit-1-dependent gonadotrope and corticotrope.
A second paired-like homeodomain factor expressed in the pituitary, rpx/Hesx1, belongs to diverse family of homeodomain proteins containing a conserved N terminal "eh-1" repressor domain originally identified in the Drosophila engrailed homeodomain (Smith & Jaynes 1996) . Like the Pitx genes, rpx expression initiates at the anterior neural plate and is later restricted to the oral ectoderm and Rathke's pouch. Attenuation of rpx expression coincides with the appearance of terminal differentiation markers for anterior pituitary cell types (Hermesz et al 1996 , Sornson et al 1996 , suggesting that rpx down-regulation is required for their developmental progression.
In Prop-1-defective mice, there is an extension of rpx expression beyond e13.5 (Gage et al 1996a , Sornson et al 1996 , and rpx/Hesx-1-deleted mice often show pituitary dysmorphogenesis, although quite distinct from the defect in Prop-1-defective Ames mice (Dattani et al 1998) . Rpx is capable of heterodimerization with Prop-1 on consensus-binding sites and can inhibit Prop-1 activity, suggesting that Rpx acts to antagonize Prop-1 function in vivo (Sornson et al 1996) . A similar type of antagonism based on heterodimerization between two paired-like homeodomain factors has also been demonstrated in Xenopus development, in which Mix1 can block the axis duplication induced by the siamois homeodomain protein (Mead et al 1996) . The functional consequences of Prop-1/Rpx interactions may therefore define the proper spatial and temporal proliferation of the pouch ectoderm into the nascent anterior pituitary gland.
Other Homeodomain Factors in Pituitary Development
The expression of several other classes of homeodomain factors in early and late pituitary ontogeny has been described, and their roles are currently under investigation. In addition to its well-documented role in the development of the eye, the paired homeobox factor Pax-6 is expressed in the oral ectoderm and becomes restricted to Rathke's pouch in early development. In the developing pituitary, Pax-6 is transiently expressed in the dorsal region of Rathke's pouch becoming down-regulated coincident with cell type differentiation. In the pituitaries of Pax-6 mutant small eye (sey) mice, there is an expansion of the ventral αGSU-expressing cell types, predominantly thyrotropes, with a reciprocal loss of the more dorsal somatotrope lineage (Bentley et al 1999 , Kioussi et al 1999 . Pax-6 therefore appears to be required for refining the dorsal/ventral boundaries between the thyrotrope/gonadotrope and somatotrope/lactotrope progenitor fields. This phenotype is reminiscent of the role that Pax6 exerts in the dorsal/ventral patterning of cell types in the neural tube, where Pax-6 acts as a negative regulator of ventral Shh signaling (Ericson et al 1997) .
In the development of the Drosophila eye, the Pax-6 homolog eyeless has been implicated to play a role in collaboration with several other nuclear factors including the Drosophila proteins sine oculus (so) and eyes absent (eya). Expression of the mammalian homologs of these proteins has been reported in the developing pituitary, including the so-related homeodomain factors Six-3 and Six-6 (Sornson et al 1996 , Jean et al 1999 . Mutations in the human SIX6 gene have been reported to be responsible for pituitary anomalies (Gallardo et al 1999) . The mammalian homologs of these Drosophila factors may also therefore contribute to the early development of the pituitary.
TRANSCRIPTIONAL CONTROL OF PITUITARY-CELL-TYPE SPECIFICATION AND HOMEOSTASIS

Pit-1 Is Required for the Generation of Three Pituitary Cell Lineages
Pit-1 is prototypic of a large family of POU domain-containing transcription factors, which contains a bipartite DNA-binding domain. The POU domain consists of an amino-terminal POU-specific domain separated by a short linker to a carboxyterminal POU homeodomain. Pit-1 (also referred to as GHF-1) was originally identified through analysis of the proteins regulating the transcription of the growth hormone and prolactin genes (Ingraham et al 1988 , Bodner et al 1988 . Genetic analysis of the Snell and Jackson dwarf mice further established that Pit-1 is required for generation of three pituitary cell lineages; somatotropes, lactotropes, and thyrotropes (Camper et al 1990 , Li et al 1990 . Because Pit-1 is directly involved in the transcriptional regulation of the hormonal markers for terminal differentiation in these cell types (e.g. GH in somatotropes, Prl in lactotropes, and TSHβ in thyrotropes), a central goal has been to address how Pit-1, in response to diverse signaling cascades and in collaboration with other factors, directs cell-specific expression of its multiple targets.
Control of Somatotrope-Specific Gene Expression
Extensive studies on the cis-active elements within the genes encoding the terminal differentiation markers of pituitary cell types have provided important insights into the mechanisms by which Pit-1 can direct cell-specific gene expression. Pit-1 binding is required to direct pituitary-specific expression in the proximal promoter region of the growth hormone gene in somatotropes. As little as 320 bp of rat GH promoter sequence is sufficient to target expression to somatotropes in vivo and contains binding sites for Pit-1, a novel zinc finger protein, and nuclear receptors (Lipkin et al 1993) . Several groups have reported cooperatively between Pit-1 and the RAR and thyroid hormone nuclear receptor in the control of GH gene expression (Schaufele et al 1992 , and recent genetic studies have supported the proposed roles for one of these nuclear receptors in the regulation GH gene expression. Mice deleted for all known isoforms of the thyroid hormone receptor show significant decreases in growth hormone expression and somatotrope cell numbers, with a reciprocal pronounced increase in TSHβ expression and thyrotropes (Gothe et al 1999) .
Further insight into the nature of somatotrope-specific gene expression has emerged from extensive promoter/enhancer mapping analyses of the human growth hormone gene. The human growth hormone locus is a cluster of five related genes, in which the most 5 gene (hGH-N) is expressed exclusively in the pituitary gland. High levels of cell-specific expression of the hGH-N require a locus control region located 14-16 kb upstream of the promoter and contain multiple DNase I hypersensitivity sites (Bennani-Baiti et al 1998), a characteristic feature of an open chromatin conformation and gene activity. In vivo and in vitro mapping studies have revealed that putative Pit-1 binding sites within the hGH-N locus control region are required for cell-specific expression (Jin et al 1999 , Shewchuk et al 1999 , further establishing the requirement of Pit-1 in the direct regulation of growth hormone gene expression.
Control of Lactotrope-Specific Gene Expression
Unlike most cell types of the pituitary gland, in which hormone gene expression can be both positively and negatively regulated by releasing hormones secreted from the hypothalamus, prolactin gene expression is controlled primarily through the negative effects of dopamine on lactotropes. Prl gene transcription is controlled through a series of distal and proximal enhancer elements containing multiple binding sites for Pit-1, which are both required and sufficient to direct cell-specific expression in vivo (Crenshaw et al 1989) . Early evidence for a cell type-specific Pit-1 synergy partner derived from studies on the Prl gene in which it was demonstrated that the estrogen nuclear receptor (ER) can activate Prl expression in cooperation with Pit-1 at a distal enhancer site . Consistent with a requirement for ER-mediated synergy, it has been demonstrated that mice deleted for the α isoform of the ER gene show a dramatic decrease in Prl gene expression and lactotrope cell numbers, with other pituitary cell types unchanged or even expanded (Scully et al 1997) .
Other factors can cooperatively regulate Prl gene expression with Pit-1 at its proximal enhancer elements. This regulation appears to involve the interplay between two ETS-domain-containing factors, Ets-1 and ERF (Ets-2 repressor factor). A pituitary-specific role for Ets-1 was initially identified through the characterization of a composite Pit-1/Ets-1 binding site in the Prl gene, which confers synergy between these proteins (Howard & Maurer 1995 , Bradford et al 1997 and is regulated through a mitogen-activated protein kinase pathway. The interaction of Pit-1 with Ets-1 is mediated by the POU homeodomain, and the functional consequences of this interaction may be modulated through use of alternative Pit-1 isoforms (Bradford et al 2000) . Furthermore, the synergy between Ets-1 and Pit-1 can be abrogated by an Ets repressor factor, ERF, apparently by inhibition of Pit-1 binding to this site (Day et al 1998) . The interplay between Ets-1, ERF, and Pit-1 thus may provide a component of the molecular mechanism for the inhibitory effects of dopamine on Prl gene expression.
A third class of factors that have been implicated in the control of Prl expression is the Pitx genes, which can also act as synergy partners for Pit-1. Both Pitx1 and Pitx2 have been demonstrated to physically associate with Pit-1, leading to synergistic activation of several pituitary-restricted genes (Szeto et al 1996 , Amendt et al 1998 , Tremblay et al 1998 . Mapping of functional domains revealed that a 39-amino-acid carboxy-terminal tail in Pitx2 acts as an autorepressive domain for DNA binding to a canonical bicoid site. Interactions between Pit-1 and Pitx2 apparently relieve this auto-repression by the carboxy-terminal tail, allowing for enhanced Pitx2 DNA binding and synergistic activation of Prl gene transcription (Amendt et al 1999) . Thus Pitx2/Pit-1 interactions appear to be another component of the complex regulation of Prl gene transcription.
Control of Thyrotrope and Gonadotrope Cell Type Specification
The third Pit-1-dependent cell type, the caudomedial thyrotrope, shares features and molecular markers in common with the non-Pit-1-dependent gonadotrope lineage. The conserved structure of the β subunits of FSH, LH (expressed in gonadotropes), and TSH (expressed in thyrotropes) and the shared common subunit αGSU suggests that these two most ventrally arising pituitary cell types evolved from a common ancestral origin. Both cell types share expression of a series of ventrally induced transcription factors including GATA-2, Isl-1, Brn4, and P-Frk, and they are determined in part by the ventral → dorsal BMP2 gradient (Treier et al 1998 , Ericson et al 1998 . Thus, a central question has been to address the mechanisms which govern the appearance of these two similar but distinct cell types.
An important distinction between these two lineages is the presence of Pit-1 in the thyrotrope and its absence in the more ventrally arising gonadotrope. As ventralized expression of Pit-1 proves sufficient to convert gonadotropes to thyrotropes in vivo (Dasen et al 1999a) , it is likely that factor(s) controlling thyrotrope development in collaboration with Pit-1 are present in gonadotropes. One of these factors has proven to be the zinc finger protein GATA-2, originally identified to be critical for the development of the hematopoietic system (Tsai et al 1994) and was later shown to be expressed in permanent pituitary cell lines derived from the αGSU lineage (Steger et al 1994) . GATA-2 has been demonstrated to play an important role in the determination of both gonadotropes and thyrotropes and is a direct transcriptional target of the ventral BMP2 signal (Figure 4) . In transgenic animals, dorsal misexpression of GATA-2 under control of Pit-1 regulatory information is alone sufficient to convert all of the Pit-1-dependent lineages to the gonadotrope fate in vivo. High levels of expression of GATA-2 are also associated with the inhibition of endogenous Pit-1 gene expression (Treier et al 1998 , Dasen et al 1999a , suggesting that high levels of GATA-2 in the ventral presumptive gonadotrope delineate this cell type from the more dorsal thyrotrope.
In presumptive caudomedial thyrotropes, the levels of GATA-2 are proposed to be insufficient to inhibit the Pit-1 gene, allowing emergence of a cell type that expresses both Pit-1 and GATA-2. Within thyrotropes, Pit-1 and GATA-2 can physically interact, leading to either synergistic activation of thyrotrope-specific genes, such as TSHβ, which contains adjacent Pit-1-and GATA-2-binding sites (Lin et al 1994 , Haugen et al 1996 , Gordon et al 1997 , or inhibition of gonadotrope-specific genes because Pit-1 can inhibit GATA-2 binding to promoters not containing an adjacent Pit-1 site (Dasen et al 1999a) . The inhibition of GATA-2 binding accounts for the ability of Pit-1, independently of its own ability to bind DNA, to inhibit expression of gonadotrope-specific genes in thyrotropes. This observation has also received genetic confirmation based on analysis of Pit-1-defective Snell dwarf mice, in which the W48C mutation in the Pit-1 POU homeodomain disrupts Pit-1/GATA-2 interactions and causes the thyrotrope to assume a gonadotrope fate. Similar context-dependent consequences of GATA/homeodomain interactions have been also observed in cardiac development, in which the interaction between Nkx-2.5 and GATA-4 can have either synergistic (Durocher et al 1997) or inhibitory (Shiojima et al 1999) effects on GATA-dependent transcription, depending on whether there is an adjacent homeodomain-binding site, suggesting that promoter-dependent functional consequences of GATA-homeodomain or 
Molecular Memory in the Enhancer Switching of the Pit-1 Gene
The regulation of Pit-1 gene expression has also presented an interesting model gene for understanding the pathways leading to the serial activation of transcription factors in pituitary development because its expression is initiated prior to the appearance of terminal differentiation markers for pituitary cell types and is temporally regulated by two distinct enhancers. Pit-1 gene expression is initiated at e13.5 by an early enhancer and subsequently switches to a late, autoregulatory enhancer between e16.5 and birth (Rhodes et al 1993 , DiMattia et al 1997 . Although the factors that govern the initiation of Pit-1 expression are yet to be identified and may include the homeodomain factor Prop-1 (Sornson et al 1996) , a component of the regulation of Pit-1 gene expression appears to involve its restriction from the gonadotrope lineage by the ventral BMP2 signal (Treier et al 1998 , Dasen et al 1999a .
As in the examples of the regulation of GH and Prl genes, a nuclear receptor/Pit-1 interaction has been demonstrated to be involved in the autoregulation of the Pit-1 gene, where RAR can act in a ligand-dependent manner to synergistically activate Pit-1 gene expression (Rhodes et al 1993) . It has been demonstrated that human combined-pituitary-hormone-deficiency patients with a mutation in the homeodomain of Pit-1 that fails to affect DNA binding show attenuated synergy of Pit-1 and RAR, providing suggestive genetic evidence that this type of nuclear receptor-homeodomain interaction is critical for determination of the Pit-1-dependent cell lineages (Cohen et al 1999b) . Thus, the switch from an early to a late acting enhancer in the Pit-1 gene may reflect the transition from a signaling factorinduced gene activation event to a permanent molecular memory loop through Pit-1 autoregulation within the three Pit-1-dependent pituitary cell lineages.
Integration of Intracellular Signaling Events by Pit-1
Within the three Pit-1-dependent pituitary cell types, a component to the regulation of cell type-specific gene expression has proved to require combinatorial interactions of Pit-1 with other cell-type-restricted factors. Because different intracellularsignaling cascades have been demonstrated to predominate within these cell types, a second level of regulation in Pit-1 activity may involve its regulated interactions with different coactivators and corepressors in response to the hypothalamic signals that activate these cascades. For example, in somatotropes GH gene transcription is regulated by the hypothalamic peptide growth hormone releasing hormone (GHRH), which binds to the GHRH receptor to activate a cAMP-mediated protein kinase A response. The importance of signaling through the GHRH receptor in somatotropes has been revealed through the analysis of little dwarf mice, in which the receptor is mutated and leads to severely reduced GH expression and somatotrope cell numbers (Godfrey et al 1993 , Lin et al 1993 . Other signaling pathways appear to predominate within other Pit-1-dependent cell types, such as the mitogen-activated-protein-kinase pathway in lactotropes, and phospholipase C pathway in thyrotropes. Thus it has been speculated that these different cascades might be involved in the differential activities of Pit-1 in different cell types or in response to the activation of different signaling pathways.
Insight into this issue has emerged from studies on the interactions of Pit-1 with transcriptional-coregulator complexes, which for activation include CREBbinding protein (CBP) and histone acetyltransferases (HATs) and, for transcriptional repression, the nuclear receptor corepressor and other histone deactylaseassociated factors. In quiescent cells, Pit-1 is a very weak transcriptional activator as it associates with members of the repressor machinery including nuclear receptor corepressor and histone deacytylases (Xu et al 1998) . Upon activation of cultured cells with cAMP or growth factors (such as insulin and epidermal growth factor), Pit-1 becomes an effective transcriptional activator, and this activity is mediated in part through interactions with coactivator CBP (Xu et al 1998 , Cohen et al 1999a .
Interestingly, activation of Pit-1 by cAMP or growth factors requires a different domain of CBP, with the amino-terminal region of CBP required for Pit-1 activation by cAMP and a carboxy-terminal domain required for activation by growth factors. These required domains also correspond to the interaction domains of CBP on Pit-1 because the Pit-1 POU domain interacts with a cystine-histidine-rich domain and a novel amino-terminal domain in CBP (Xu et al 1998 , Zanger et al 1999 . Furthermore, the stimulation of Pit-1 activity by cAMP and growth factors also requires different HAT-containing coregulators because cAMP-stimulated cells require the HAT domain of CBP whereas cells stimulated with growth factors require the HAT domain of another transcriptional coregulator, p/CAF. Thus, the activity of Pit-1 in response to different signals can be regulated through modulation of its interactions with components of the transcriptional-activation machinery, likely leading to cell-type-specific effects on the chromatin associated with the regulatory sequences of specific subsets of genes.
Control of Gonadotrope-Specific Gene Expression
Of the non-Pit-1-dependent pituitary cell lineages, the best characterized at the molecular level are the gonadotropes, which arise in the most ventral region of the pituitary gland. The regulated control of the genes for the terminal-differentiation markers for gonadotrope development, which include LHβ and FSHβ, require the activities of multiple transcription factors, including SF-1, Egr-1, and Pitx1 (Ingraham et al 1994 , Lee et al 1996 , Topilko et al 1998 . Egr-1 (also referred to as NGFI-A, Krox-24, and Zif 268) is a zinc finger containing protein homologous to the Wilms tumor gene product, which synergizes with the orphan nuclear receptor SF-1 on the LHβ promoter (Lee et al 1996) and is rapidly induced in gonadotrope-derived pituitary cell lines treated with gonadotropinreleasing hormone (GnRH) (Tremblay & Drouin 1999) . Pitx1 and SF-1 also cooperatively regulate LHβ, through association of the carboxyl terminus of Pitx1 with the amino terminus of SF-1. The interaction of Pitx1 and SF-1 is reminiscent of interactions of Pitx factors and Pit-1, and this transcriptional synergy does not appear to require Pitx1 DNA binding.
Analysis of mice bearing targeted mutations in the genes for Egr-1, SF-1, and Pitx1 have revealed distinctive roles for each of these factors in gonadotropin synthesis. Mice disrupted in Egr-1 show specific defects in LHβ expression, with expression of the FSHβ gene unchanged (Lee et al 1996 , Topilko et al 1998 . Surprisingly, Egr-1-deficient mice are also characterized by reduced somatotrope numbers, although this defect appears to be background strain specific (Topilko et al 1998) . Defects in gonadotrope proliferation and hormone synthesis are also observed in SF-1 gene-deleted mice, although it is unclear whether this defect is due to defective GnRH synthesis because SF-1 is also required in the development of hypothalamic GnRH-producing neurons. Similarly, Pitx1 gene-deleted animals are also characterized by reduced gonadotrope cell numbers, although specification of the lineage appears normal.
Understanding the mechanisms controlling expression of the αGSU gene regulation has presented an interesting problem in pituitary development because its expression can be controlled by distinct mechanisms within gonadotropes and thyrotropes, and it is regulated by series of distinct cis-acting elements directing expression in a cell-restricted manner. As little as 313 bp of the proximal bovine promoter sequences, containing sites for Lhx/Pitx/CLIM synergy as well as GATA-2/3 and SF-1, are required to target αGSU expression to gonadotropes in transgenic mice (Kendall et al 1991 , Steger et al 1994 , Bach et al 1997 . Full activity and cell type-specific expression of the murine αGSU gene require a more distal enhancer element (Brinkmeier et al 1998 , Kendall et al 1994 , and this element is also apparently required for the restriction of αGSU expression from other pituitary cell types because it can confer repression of basal αGSU promoter activity in somatotrope-representative pituitary cell lines (Wood et al 1999) . The regulatory region of the αGSU gene therefore presumably contains elements required for both its cell-specific activation in thyrotropes and gonadotropes and restriction from other pituitary cell types. This regulatory region contains potential binding sites for several factors including Ets, GATA, and HLH factors (Wood et al 1999) , although the contribution of these elements to the activation and restriction of αGSU expression in different pituitary cell types is yet to be determined.
Control of Melanotrope-and Corticotrope-Specific Gene Expression
Considerably less is known about the cell-autonomous factors governing the appearance of the two pituitary cell types that share expression of the POMC gene, corticotropes and melanotropes. Of the currently existing mouse dwarf strains and gene-deleted animals for pituitary-restricted transcription factors, none is characterized by the complete absence of corticotropes and melanotropes; thus genetic mouse models to address the development of these cell types are lacking. Although the signaling factors that positionally determine the POMC lineages appear to include LIF and FGFs, the specific transcription factors that specify these cell types remain elusive. Analysis of regulatory elements in the POMC promoter have revealed binding sites for several factors including a bicoid-binding site and the orphan nuclear receptor Nur77 (Philips et al 1997) . The relevance of these sites in the regulation of POMC in vivo remains to be determined.
The best characterized component of the transcriptional regulation of corticotrope-and melanotrope-specific gene expression has been the negative-feedback regulation of the POMC gene by the glucocorticoid receptor (GR) (Therrien & Drouin 1993) . The POMC gene contains a negative DNA response element in which GR acts in a ligand-dependent manner to inhibit POMC expression in corticotropes in response to elevated levels of glucocorticoids. Consistent with this observation, in GR gene-deleted animals there is dramatic increase in POMC expression in corticotropes within the anterior lobe of the pituitary (Reichardt & Schutz 1996) . Interestingly, the inhibition of POMC expression is not dependent on GR DNA binding because mice carrying a targeted mutation in the GR DNAbinding domain are also characterized by increased POMC expression (Reichardt et al 1998) . This observation is consistent with the hypothesis that nuclear receptors can act to trans-repress certain target genes off DNA. Furthermore, there appear to be significant differences between the regulation of POMC in the anterior lobe (corticotropes) and the intermediate lobe (melanotropes) in mice. In the intermediate lobe, GR appears to be required to activate POMC because POMC expression is dramatically reduced in GR-knockout animals. The molecular mechanisms behind this cell-type-specific functional difference remain to be elucidated.
CONCLUSIONS AND FUTURE DIRECTIONS
Taken together, the studies described here begin to define a model encompassing the extrinsic and intrinsic signaling mechanisms governing the early and late aspects of pituitary development ( Figure 5) . A series of signaling molecules secreted from multiple organizing centers appears to coordinate the commitment, early patterning, proliferation, and positional determination of six hormone-producing pituitary cell types. Secretion of BMP4 from the ventral diencephalon appears to be required for the initial phases of pituitary organ commitment, with subsequent opposing and antagonistic dorsal FGF8 and ventral BMP2 gradients governing the patterning and positional determination of cell types through the induction of overlapping patterns of transcription factor gene expression. The establishment of these distinct expression patterns allows the positional determination of pituitary cell types to occur long before the cell-type-specific terminal differentiation markers appear. Future studies will attempt to encompass the still undefined roles for other signaling molecules such as Shh, RA, and LIF, which may be involved in the induction or modulation of other signaling gradients and transcription factor function.
The earliest phases of pituitary development have been established to be mediated through the activities of the transcription factors Pitx2 and Lhx3/4, which are required for the early patterning and proliferation events within Rathke's pouch. The critical step in defining the activities of these early factors is the induction of Lhx3 gene expression in response to dorsal FGF gradients originating from the infundibulum. Later proliferation and cellular-determination events require the activities of several induced factors including Prop-1, Pit-1, and GATA-2. Given the established roles of these factors in the generation of specific cell phenotypes, a complete understanding of how broadly expressed signaling molecules can generate an organ-specific determination program will require knowledge of how these and other pituitary-restricted transcription factors are induced. This will undoubtedly require further investigations into the multiple downstream targets of the signaling pathways and the elucidation of the factors whose activities are directly modulated by the early morphogen gradients.
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Visit the Annual Reviews home page at www.AnnualReviews.org Figure 1 The hypothalamic-pituitary axis. Hormone synthesis and secretion from the pituitary gland are regulated by a series of peptide hormones released from hypothalamic neurons. The magnocellular neurosecretory system includes neurons in the paraventricular hypothalamus (PVH) and supraoptic (SO) nuclei that synthesize the peptide hormones oxytocin (OT) and arginine vasopressin (AVP) and release them in an activity-dependent manner from axonal terminals in the posterior lobe (P) of the pituitary gland. In addition, the PVH harbors separate populations of parvocellular cells, which synthesize corticotropinreleasing hormone (CRH) and thyrotropin-releasing hormone (TRH). These neuropeptides are delivered to the median eminence for conveyance via the hypophyseal-portal vascular system to modulate the synthesis and release of ACTH and TSH in the anterior pituitary gland (A). Centered in ventrally contiguous cell groups in the anterior periventricular (AVP) or the arcuate nuclei (ARH) of the hypothalamus are hypophysiotrophic neurons that provide both the dopaminergic (DA) control of prolactin (PRL) secretion and somatostatin (SS) or growth hormone-releasing hormone (GHRH) which impart the principal inhibitory and stimulatory regulation of growth hormone (GH), respectively. Cells of the intermediate lobe (I) of the pituitary gland produce melanocyte-stimulating hormone (MSH) by proteolytic processing of POMC (not shown). with the overlying neural epithelium (ne) by e9.0 in the mouse with Sonic hedgehog (Shh) becoming excluded from the region which forms Rathke's pouch. The neural epithelium of the ventral diencephalon, which makes contact with the pouch (the infundibulum), expresses BMP4, FGF8, and Wnt5a, while BMP2 is expressed within Rathke's pouch at the Shh restriction boundary and within the ventral mesenchyme. Multiple transcription factors are expressed throughout the oral ectoderm, with the expression of the transcription factor Lhx3 restricted to Rathke's pouch. Opposing dorsal FGF8 and ventral BMP2 gradients are associated with the spatially restricted expression patterns of transcription factors by e10-e11, including a series of dorsally or ventrally induced factors, and they allow for the positional commitment of cell lineages.
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Figure 3
Role of Prop-1 and Pit-1 in murine and human pituitary development. Based on the molecular analysis of Ames (df ) mice, the homeodomain factor Prop-1 has been shown to be required for the ventral progression of anterior pituitary cell types and extinction of Rpx expression between days e12 and e13. Analysis of Snell (dw) mice has revealed a requirement for the POU homeodomain factor Pit-1 in generation of three cell lineages. Multiple human alleles for mutations in the human PROP1 gene have revealed a requirement for Prop-1 in the generation of a non-Pit-1-dependent cell lineage, the gonadotrope. anterior neural ridge are committed to the pituitary fate through the induction of Lhx3/P-LIM expression, which may require the combinatorial actions of FGF8, BMP4, and Shh. Pitx2 is required for the expansion of these precursors within Rathke's pouch, with Prop-1 required for the asymmetric ventral proliferation and determination of at least four cell types. The transcriptional activities of Prop-1 are hypothesized to be antagonized by the homeodomain repressor factor Rpx/Hesx1. Pit-1 is subsequently required for the cell fate determination of three cell types (somatotropes, lactotropes, and thyrotropes), whereas GATA-2 is hypothesized to be required for the thyrotrope and gonadotrope cell lineages, based on the presence or absence of Pit-1, respectively.
